Alan Pollack, MD, PhD
@_apollack
Chair and Professor of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
ID: 1003390553579548673
03-06-2018 21:38:44
15 Tweet
213 Followers
10 Following
Radiation Nation The Lancet Yes, GETUG AFU-16 and RTOG 9601 are the main complimentary randomized trials to the SPPORT trial. The GETUG trial is the most comparable, because both SPPORT and GETUG used short term ADT. All three trials showed outcome benefits from the addition of ADT to prostate bed RT.